66,163 research outputs found

    Prevalence and Prognostic Significance of Wall-Motion Abnormalities in Adults without Clinically Recognized Cardiovascilar Disease

    Get PDF

    Riemannian Walk for Incremental Learning: Understanding Forgetting and Intransigence

    Get PDF
    Incremental learning (IL) has received a lot of attention recently, however, the literature lacks a precise problem definition, proper evaluation settings, and metrics tailored specifically for the IL problem. One of the main objectives of this work is to fill these gaps so as to provide a common ground for better understanding of IL. The main challenge for an IL algorithm is to update the classifier whilst preserving existing knowledge. We observe that, in addition to forgetting, a known issue while preserving knowledge, IL also suffers from a problem we call intransigence, inability of a model to update its knowledge. We introduce two metrics to quantify forgetting and intransigence that allow us to understand, analyse, and gain better insights into the behaviour of IL algorithms. We present RWalk, a generalization of EWC++ (our efficient version of EWC [Kirkpatrick2016EWC]) and Path Integral [Zenke2017Continual] with a theoretically grounded KL-divergence based perspective. We provide a thorough analysis of various IL algorithms on MNIST and CIFAR-100 datasets. In these experiments, RWalk obtains superior results in terms of accuracy, and also provides a better trade-off between forgetting and intransigence

    Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population with High Prevalence of Obesity and Diabetes: The Strong Heart Study.

    Get PDF

    Monoclonal antibody against cadherin-17 as a potential treatment for liver cancer

    Get PDF
    This journal suppl. entitled: Abstracts of The International Liver Congress™ 2012 – 47th annual meeting of the European Association for the Study of the Liver / Poster AbstractsBACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is a major type of liver cancer associated with high mortality. Prognosis is poor in HCC patients largely because of late diagnosis and limitations in treatment options. Therefore, this study aims to identify alternative target for HCC in hope to offer new treatments to patients. Cadherin-17 (CDH17) has been identified as an oncofetal molecule of HCC and that a suppression of its expression by RNA interference (RNAi) leads to anti-tumorigenesis. To supplement the drawbacks associated with the use of RNAi approach in biotherapy, we developed specific antibody against CDH17 for achieving similar purpose. METHODS: Hybridoma cell clones capable of secreting antibodies ...postprin
    • …
    corecore